NO20032471L - Farnesyltransferaseinhibitorer - Google Patents

Farnesyltransferaseinhibitorer

Info

Publication number
NO20032471L
NO20032471L NO20032471A NO20032471A NO20032471L NO 20032471 L NO20032471 L NO 20032471L NO 20032471 A NO20032471 A NO 20032471A NO 20032471 A NO20032471 A NO 20032471A NO 20032471 L NO20032471 L NO 20032471L
Authority
NO
Norway
Prior art keywords
farnesyl transferase
farnesyltransferase
inhibiting
thiazoles
patient
Prior art date
Application number
NO20032471A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032471D0 (no
Inventor
Akiyo K Claiborne
Ii Stephen L Gwaltney
Lisa A Hasvold
Qun Li
Tomgmei Li
Nan-Horng Lin
Robert A Mantei
Todd W Rockway
Hing L Sham
Gerard M Sullivan
Yunsong Tong
Gary T Wang
Le Wang
Xilu Wang
Weibo Wang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20032471D0 publication Critical patent/NO20032471D0/no
Publication of NO20032471L publication Critical patent/NO20032471L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20032471A 2000-11-30 2003-05-30 Farnesyltransferaseinhibitorer NO20032471L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72723000A 2000-11-30 2000-11-30
US09/912,677 US20020115640A1 (en) 2000-11-30 2001-07-25 Farnesyltransferase inhibitors
PCT/US2001/043168 WO2002074747A1 (en) 2000-11-30 2001-11-30 Farnesyltransferase inhibitors

Publications (2)

Publication Number Publication Date
NO20032471D0 NO20032471D0 (no) 2003-05-30
NO20032471L true NO20032471L (no) 2003-07-25

Family

ID=24921844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032471A NO20032471L (no) 2000-11-30 2003-05-30 Farnesyltransferaseinhibitorer

Country Status (31)

Country Link
US (1) US20020115640A1 (zh)
EP (1) EP1339695B1 (zh)
JP (1) JP2004519503A (zh)
KR (1) KR20030060968A (zh)
CN (1) CN1487924A (zh)
AR (1) AR035375A1 (zh)
AT (1) ATE323681T1 (zh)
BG (1) BG107908A (zh)
BR (1) BR0112028A (zh)
CA (1) CA2430619A1 (zh)
CY (1) CY1106104T1 (zh)
CZ (1) CZ20031804A3 (zh)
DE (1) DE60118955T2 (zh)
DK (1) DK1339695T3 (zh)
EC (1) ECSP034634A (zh)
ES (1) ES2261340T3 (zh)
HK (1) HK1059260A1 (zh)
HU (1) HUP0600331A2 (zh)
IL (2) IL156212A0 (zh)
MX (1) MXPA03004879A (zh)
MY (1) MY136181A (zh)
NO (1) NO20032471L (zh)
NZ (1) NZ526313A (zh)
PE (1) PE20020687A1 (zh)
PL (1) PL363637A1 (zh)
PT (1) PT1339695E (zh)
SA (1) SA01220565B1 (zh)
SI (1) SI1339695T1 (zh)
SK (1) SK286686B6 (zh)
UY (1) UY27046A1 (zh)
WO (1) WO2002074747A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008539276A (ja) * 2005-04-27 2008-11-13 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド ヒト疾患に関連する変異体タンパク質の分解能を改善するための材料及び方法
JP4592548B2 (ja) * 2005-08-24 2010-12-01 株式会社エヌ・ティ・ティ・ドコモ 送信電力制御方法及び移動通信システム
US7722316B2 (en) * 2005-09-13 2010-05-25 Rolls-Royce Power Engineering Plc Acoustic viscous damper for centrifugal gas compressor
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806284A (en) * 2006-03-31 2008-02-01 Alcon Mfg Ltd Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084477B2 (en) * 2007-10-31 2011-12-27 Bristol-Myers Squibb Company Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
US20110086834A1 (en) * 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
EP2643031B1 (de) * 2010-11-26 2015-06-24 Reza Ghotbi Implant zur behandlung oder prävention eines aneurysmas
CN105693617B (zh) * 2014-11-24 2018-06-08 中国科学院大连化学物理研究所 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法
EP3360233B1 (en) 2015-10-07 2021-08-04 Tc1 Llc Resonant power transfer systems having efficiency optimization based on receiver impedance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036901A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6297239B1 (en) * 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
BR9913315A (pt) * 1998-08-27 2001-05-22 Pfizer Prod Inc Derivados de quinolin-2-ona úteis como agentes anticâncer

Also Published As

Publication number Publication date
ECSP034634A (es) 2003-07-25
BG107908A (bg) 2004-01-30
HUP0600331A2 (en) 2006-10-28
WO2002074747A1 (en) 2002-09-26
CY1106104T1 (el) 2011-06-08
CZ20031804A3 (cs) 2003-11-12
ATE323681T1 (de) 2006-05-15
IL156212A (en) 2008-11-26
SA01220565B1 (ar) 2007-01-27
UY27046A1 (es) 2002-07-31
NO20032471D0 (no) 2003-05-30
EP1339695A1 (en) 2003-09-03
EP1339695B1 (en) 2006-04-19
MXPA03004879A (es) 2004-05-04
JP2004519503A (ja) 2004-07-02
NZ526313A (en) 2004-11-26
SK8232003A3 (en) 2004-01-08
DE60118955D1 (de) 2006-05-24
AR035375A1 (es) 2004-05-12
US20020115640A1 (en) 2002-08-22
PT1339695E (pt) 2006-08-31
PL363637A1 (en) 2004-11-29
SI1339695T1 (sl) 2006-10-31
IL156212A0 (en) 2003-12-23
DE60118955T2 (de) 2007-01-04
PE20020687A1 (es) 2002-08-03
BR0112028A (pt) 2004-02-17
MY136181A (en) 2008-08-29
CN1487924A (zh) 2004-04-07
HK1059260A1 (en) 2004-06-25
DK1339695T3 (da) 2006-07-31
CA2430619A1 (en) 2002-09-26
ES2261340T3 (es) 2006-11-16
SK286686B6 (sk) 2009-03-05
KR20030060968A (ko) 2003-07-16

Similar Documents

Publication Publication Date Title
BR0112965A (pt) Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inibidores de glocogênio sintase cinase-3beta
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
NO971537L (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer for metalloproteaser
BR0014075A (pt) Inibidores de quinase como agentes terapêuticos
NO20032471L (no) Farnesyltransferaseinhibitorer
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
PL377628A1 (pl) N3 Alkilowane pochodne benzoimidazolu, kompozycja je zawierająca oraz ich zastosowanie do wytwarzania leku do leczenia zaburzeń hiperproliferacyjnych
NO20051339L (no) Anvendelse av lkB-kinaseinbibitorer ved behandling av smerte.
UY27972A1 (es) Derivados de hidantoína
ATE401314T1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
ECSP003699A (es) Inhibidores de fab i
EP1165490A4 (en) INHIBITORS OF SUBSTITUTED 2-AMINOBENZAMIDIC CASPASES AND THEIR USE
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
NO20052991L (no) Kinazolinforbindelser.
ATE409189T1 (de) Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate
DE502004007922D1 (de) Ketolactam-verbindungen und ihre verwendung
GB0112348D0 (en) Compounds
DE60042401D1 (de) Fab-i inhibitoren
DE60324461D1 (de) Therapeutische quinazolin-derivate
TW200504019A (en) Diphenylpyridine derivatives, preparation thereof and application thereof in therapeutics
ATE380797T1 (de) Prenyl-transferase inhibitoren
TW200420545A (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
NO20015857L (no) Nye derivater og analoger av galantamin
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren

Legal Events

Date Code Title Description
ERR Erratum

Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING

Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING.

FC2A Withdrawal, rejection or dismissal of laid open patent application